Anticorps Recombinant de lapin anti-SLC7A11/xCT

SLC7A11/xCT Recombinant Antibody for IF/ICC, FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, IF/ICC, FC (Intra), ELISA

Conjugaison

Non conjugué

Publications(3)

CloneNo.

230227C5

N° de cat : 82115-2-RR

Synonymes

SLC7A11, xCT, 230227C5, Amino acid transport system xc, Amino acid transport system xc-



Applications testées

Résultats positifs en IF/ICCcellules A549,
Résultats positifs en FC (Intra)cellules A549, cellules HeLa

Dilution recommandée

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:125-1:500
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

82115-2-RR cible SLC7A11/xCT dans les applications de WB, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène SLC7A11/xCT Protéine recombinante Ag25431
Nom complet solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
Masse moléculaire calculée 55 kDa
Numéro d’acquisition GenBankBC012087
Symbole du gène SLC7A11
Identification du gène (NCBI) 23657
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.

Protocole

Product Specific Protocols
IF protocol for SLC7A11/xCT antibody 82115-2-RRDownload protocol
FC protocol for SLC7A11/xCT antibody 82115-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Immunol

A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma

Authors - Haishui Zheng
humanWB

Biofactors

Induction of UBQLN1-mediated PGC1α stability by isoliensinine overcame hypoxia-induced resistance in liver cancer cells

Authors - Xuefen Xu
mouseIF

Ren Fail

Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production

Authors - Yan Tian
{{ptg:RelatedPrimaryAntibodies}}